Huahai Pharmaceutical convertible bonds trigger optional put-back

Zhejiang Huahai Pharmaceutical Co., Ltd. announced the activation of the optional put-back clause for its "Huahai convertible bonds." This follows the company's stock price closing below 70% of its current conversion price for 30 consecutive trading days between November 2, 2025, and December 12, 2025.

Bondholders can choose to put back their convertible bonds at a price of 100.30 yuan per bond, which includes accrued interest and tax. The put-back declaration period is set from December 22, 2025, to December 26, 2025, with fund disbursement scheduled for December 31, 2025.

During the put-back period, the "Huahai convertible bonds" will continue to trade but will be suspended from conversion. Bondholders are advised that the put-back is optional and not mandatory. The current closing price of the bonds is higher than the put-back price, meaning bondholders who choose to exercise the put-back option might incur losses.

The accrued interest (I₁) is calculated using the formula: I₁=B×i×t/365, where B is the total face value of the bonds, i is the annual coupon rate (2.00% for the sixth year), and t is the number of days (54 days from November 2, 2025, to December 26, 2025). This results in an interest payment of approximately 0.30 yuan per bond. For further inquiries, bondholders may contact the Securities Management Department at 0576-85015699.